AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

DICLOFENAC SODIUM in Zimbabwe

28 products registered with MCAZ β€” 28 active

Brand / ProductReg. No.HolderStatusExpires
DINAC GEL
GEL
2026/3.1/7365S KANT HEALTHCARE LTDactive25 Mar 2031
CP-DICLOFENAC EYE DROPS
SUSPENSION/DROPS; OPHTHALMIC
2025/19.1/7090COSPHARM INVESTMENTS South Africaactive8 Oct 2030
NONE
SOLUTION; INJECTION
2025/3.1/7071ARAVAS PHARMACEUTICALSactive23 Sept 2030
SKYPHARM DICLOFENAC SODIUM SUPPOSITORIES 100MG
SUPPOSITORY; RECTAL
2026/3.1/7363ADVENTURA INVESTMENTS LTDactive31 Dec 2027
VOLTNEX
SOLUTION; INJECTION
2024/3.1/6540NOVO MEDI SCIENCES PVT LTDactive31 Dec 2027
REMETHAN 25 EC
TABLET, COATED; ORAL
99/3.1/3620REMEDICA LTDactive31 Dec 2027
TRI-DICLOFENAC
INJECTABLE; INJECTION
2019/3.1/5823INNOVATA PHARMACEUTICALSactive31 Dec 2027
VIVIAN
SOLUTION/DROPS; OPHTHALMIC
2021/19.10. /6092LINCOLN PHARMACEUTICALS LIMITEDactive31 Dec 2027
PANAMOR AT-50
TABLET, COATED; ORAL
91/3.1/2562PHARMACARE LIMITEDactive31 Dec 2027
DICLOFENAC
TABLET; ORAL
2008/3.1/4533PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/Lactive31 Dec 2027
DICLOZED
INJECTABLE; INJECTION
2016/3.1/5277SAKAR HEALTHCARE PVT LTDactive31 Dec 2027
PANAMOR 25
TABLET, COATED; ORAL
91/3.1/2561PHARMACARE LIMITEDactive31 Dec 2027
VIVIAN-25
TABLET, COATED; ORAL
2004/3.1/4303PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/Lactive31 Dec 2027
VOLTAREN
TABLET, COATED; ORAL
86/3.1/1876NOVARTIS PHARMACEUTICAL CORPORATIONactive31 Dec 2027
MSAADA OVERNIGHT
SUPPOSITORY; RECTAL
2022/3.1/6329SAPPS PHARMACEUTICALSactive31 Dec 2027
MSAADA
SUPPOSITORY; RECTAL
2022/3.1/6328SAPPS PHARMACEUTICALSactive31 Dec 2027
VOLTAREN
SUPPOSITORY; RECTAL
77/3.1/884NOVARTIS PHARMACEUTICAL CORPORATIONactive31 Dec 2027
VOVENIL
SOLUTION; INJECTION
2024/3.1/6529COSPHARM INVESTMENTS PVT LTDactive31 Dec 2027
BIORAN
TABLET, COATED; ORAL
2007/3.1/4505RUSAN PHARMA LTDactive31 Dec 2027
DICLOFENAC
INJECTABLE; INJECTION
2012/3.1/4752KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTDactive31 Dec 2027
DICLOFENAC SODIUM
TABLET, COATED; ORAL
2000/3.1/3763BAL PHARMAactive31 Dec 2027
DICLOFENAC SODIUM
TABLET, COATED; ORAL
2001/3.1/3891CAPS PVT LTDactive31 Dec 2027
DIKLORON
SOLUTION; INJECTION
2024/3.1/6677ACCESS PHARMACEUTICALSactive31 Dec 2027
SKY PHARM-DICLOFENAC
SUPPOSITORY; RECTAL
2018/14.15/5621ADVENTURA INVESTMENTS LIMITEDactive31 Dec 2027
ALMIRAL
INJECTABLE; INJECTION
2015/3.1/4975MEDOCHEMIE LTDactive31 Dec 2027
DICURE
SOLUTION; INJECTION
2025/3.1/6930PHARMACURE DISTRIBUTORS (PVT) LTDactive31 Dec 2027
LOFNAC 50
TABLET, COATED; ORAL
2024/3.1/6636COSPHARM INVESTMENTS (PTY) LTDactive31 Dec 2027
RELAXO
SOLUTION; INJECTION
2018/3.1/5707LINCOLN PHARMACEUTICALS LIMITEDactive31 Dec 2027

DICLOFENAC SODIUM β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 28 registered products containing DICLOFENAC SODIUM, of which 28 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track DICLOFENAC SODIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Diclofenac Sodium β€” Zimbabwe (MCAZ) | AfricaRegulatory